Voyageur Pharmaceuticals Ltd V.VM

Alternate Symbol(s): VYYRF

Healthcare Drug Manufacturers - Specialty & Generic

Voyageur Pharmaceuticals Ltd. is a Canada-based company engaged in the development of barium and iodine Active Pharmaceutical Ingredients (API) and offers high-performance imaging contrast agents. The Company is focused on vertically integrating the barium and iodine contrast market, and aims at producing its own barium, iodine, and endo fullerenes. The Company’s products include SmoothX, SmoothHD, SmoothLD, VisionHD, VisionLD and V-Gas. SmoothX (2%w/v) is a contrast medium for use in computed tomography (CT) of the gastrointestinal tract. VisionHD is a high-density (98% w/w) barium powder suspension tailored for double-contrast radiographic examination of the gastrointestinal tract, esophagus, stomach and duodenum. It also owns a 100% interest in the Frances Creek barium sulfate (barite) project, which is a rare grade mineral suitable for the pharmaceutical marketplace that is intended to replace the current synthetic products with quality imaging products.

TSXV:VM - Post by User

Voyageur Pharmaceuticals Ltd > Big Boys on Defensive

<< Previous

Bullboard Posts

Next >>

Comment by Budd22on Feb 17, 2023 12:09pm

102 Views

Post# 35292260

RE:RE:RE:RE:Big Boys on Defensive

FDA approval In 4-5 years? Lol explain. Company can apply after 6 month batch testing if everything goes well and they already have begun the process. It takes up to 120 days to be approved after submission.

Everything is slow with the government tho so I would give it til 1st Q 2024.

<< Previous

Bullboard Posts

Next >>

Paramount Resources signs $3.32 billion asset sale